Vimarsana
Biggest News Aggregation in the World

Page 9 - Cell Cycle News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Cycle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Cycle Today - Breaking & Trending Today

Different cellular building blocks are not produced at the same time, research shows - Vimarsana News

Different cellular building blocks are not produced at the same time, research shows

Textbooks will tell you that in dividing cells, the production of new DNA peaks during the S-phase, while production of other macromolecules, such as proteins, lipids, and polysaccharides, continues at more or less the same level.

A new trial to assess if butyrate can prevent colon cancer - Vimarsana News

A new trial to assess if butyrate can prevent colon cancer

Researchers discuss a new clinical trial that will determine the efficacy of butyrate administration in preventing colon cancer.

Characterization of Ikaros zinc finger protein 1 mutations in acute myeloid leukemia - Vimarsana News

Characterization of Ikaros zinc finger protein 1 mutations in acute myeloid leukemia

Researchers evaluated the clinical and genetic characteristics of acute myeloid leukemia (AML) patients with a mutant Ikaros zinc finger protein 1 (IKZF1).

Researchers discover a key role played by ch-TOG protein in the initiation of microtubule assembly - Vimarsana News

Researchers discover a key role played by ch-TOG protein in the initiation of microtubule assembly

Microtubules are cellular fibres that are part of the skeleton of the cell, termed cytoskeleton. They ensure that cells maintain their shape, carry out their functions, and divide.

Study uncovers protein that acts as a brake for DNA replication - Vimarsana News

Study uncovers protein that acts as a brake for DNA replication

A protein that prepares DNA for replication also prevents the replication process from running out of control, according to a new study by Weill Cornell Medicine researchers.